{"id":58141,"date":"2021-12-15T14:50:00","date_gmt":"2021-12-15T14:50:00","guid":{"rendered":"https:\/\/www.atlasrleye.com\/exudative-armd\/clinical-case-3\/"},"modified":"2024-01-27T15:52:23","modified_gmt":"2024-01-27T15:52:23","slug":"clinical-case-3","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/age-related-macular-degeneration\/exudative-armd\/clinical-case-3\/","title":{"rendered":"Clinical Case 3"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”AGE-RELATED MACULAR DEGENERATION” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231635506431773-0d8d0743-1f0b|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Exudative ARMD – Clinical Case 3″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fage-related-macular-degeneration%2Fexudative-armd%2F|title:Exudative%20ARMD|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\"\"OCT vertical line-scan of an exudative age-related macular degeneration with choroidal neovascular membrane and subretinal hemorrhage, in an 80 years-old male patient. Visual acuity: < 20\/400 RE.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”24238″ img_size=”medium” alignment=”center” onclick=”link_image”][\/vc_column_inner][vc_column_inner width=”1\/2″ css=”.vc_custom_1643630226999{margin-top: -10px !important;}”][vc_column_text]<\/p>\n

OCT vertical line-scan in same case, after two treatments with intravitreal injection of bevacizumab, showing recovery of macular structure.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row content_placement=”middle”][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 04 05 2011″ tab_id=”1636641179216-cb4f444c-b7b1″][vc_row_inner content_placement=”middle”][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Angiography with Green Indocyanine<\/p>\n

\n

Indocianine green angiogram demonstrating choroidal neovascular membrane.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24217,24178″ img_size=”193×206″ css=”.vc_custom_1706369950810{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner content_placement=”middle”][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Fluorescein Angiography<\/p>\n

\n

Fluorescein angiogram at mid-phase demonstrating macular leakage.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24208,24211,24214″ img_size=”193×206″ css=”.vc_custom_1706369923219{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24190″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24193″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24187″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24196,24199,24202,24205″ img_size=”410×110″ css_animation=”none” el_class=”wplightbox”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/4″][vc_gallery type=”image_grid” images=”24181″ img_size=”251×206″][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_gallery type=”image_grid” images=”24184″ img_size=”251×250″][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – 13 10 2011″ tab_id=”1638898543320-34df8e39-ed5d”][vc_row_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24232″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24235″ img_size=”193×206″][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24229″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24238,24241,24244,24220″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/span><\/p>\n

\n

Fundus photograph after 2 injections of intraocular bevacizumab. The subretinal hemorrhage was reabsorbed.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/4″][vc_gallery type=”image_grid” images=”24223″ img_size=”251×206″ css=”.vc_custom_1706369996044{margin-top: -30px !important;}”][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_gallery type=”image_grid” images=”24226″ img_size=”251×250″ css=”.vc_custom_1706370002197{margin-top: -30px !important;}”][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 22 11 2012″ tab_id=”1639580286158-62c45005-5eeb”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24247,24250″ img_size=”193×206″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24253,24256,24259,24262″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour Retinography<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_gallery type=”image_grid” images=”24265,24268″ img_size=”251×206″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”4th Evaluation – 12 12 2013″ tab_id=”1639580384824-662605cb-ab73″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24274,24277,24280,24271″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”5th Evaluation – 10 07 2014″ tab_id=”1639580442999-a3378d64-1fe7″][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/span><\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”24286,24289,24292,24283″ img_size=”307×110″][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”AGE-RELATED MACULAR DEGENERATION” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fatlas%2F%231635506431773-0d8d0743-1f0b|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ add_icon=”true” css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Exudative ARMD – Clinical Case 3″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fage-related-macular-degeneration%2Fexudative-armd%2F|title:Exudative%20ARMD|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner][vc_column_text] OCT vertical line-scan of an exudative age-related macular […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":58096,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-58141","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/58141","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=58141"}],"version-history":[{"count":15,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/58141\/revisions"}],"predecessor-version":[{"id":94333,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/58141\/revisions\/94333"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/58096"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=58141"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}